2,5,8,11-Tetraoxatridecan-13-yl 2-((2'-((6-azidohexyl)oxy)-5-((3-ethynylphenyl)diazenyl)-[1,1'-biphenyl]-2-yl)oxy)acetate

Catalog No. :
ACDRZV529
CAS No. :
1784703-80-5
Molecular Formula :
C37H45N5O8
Molecular Weight :
687.79

IUPAC Name:2,5,8,11-tetraoxatridecan-13-yl 2-((2'-((6-azidohexyl)oxy)-5-((3-ethynylphenyl)diazenyl)-[1,1'-biphenyl]-2-yl)oxy)acetate

2,5,8,11-Tetraoxatridecan-13-yl 2-((2'-((6-azidohexyl)oxy)-5-((3-ethynylphenyl)diazenyl)-[1,1'-biphenyl]-2-yl)oxy)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5,8,11-Tetraoxatridecan-13-yl 2-((2'-((6-azidohexyl)oxy)-5-((3-ethynylphenyl)diazenyl)-[1,1'-biphenyl]-2-yl)oxy)acetate
IUPAC Name2,5,8,11-tetraoxatridecan-13-yl 2-((2'-((6-azidohexyl)oxy)-5-((3-ethynylphenyl)diazenyl)-[1,1'-biphenyl]-2-yl)oxy)acetate
Molecular FormulaC37H45N5O8
Molecular Weight687.79
SMILESC#CC1=CC(N=NC2=CC=C(OCC(=O)OCCOCCOCCOCCOC)C(C3=CC=CC=C3OCCCCCCN=[N+]=[N-])=C2)=CC=C1
InChI KeyNWRNIQPRPCDLPA-UHFFFAOYSA-N
SynonymAcetic acid, 2-[[2'-[(6-azidohexyl)oxy]-5-[2-(3-ethynylphenyl)diazenyl][1,1'-biphenyl]-2-yl]oxy]-, 3,6,9,12-tetraoxatridec-1-yl ester
CAS No.1784703-80-5

Synthetic Route by SureRoute

1. ACDRZV529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFLDZ740 route compound structure diagram
    ACFLDZ74023783-42-8 In Stock
  4. Then
  5. ACDRZV529 route product structure diagram
    ACDRZV5291784703-80-5
Inquiry

2. ACDRZV529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDRZV529 route product structure diagram
    ACDRZV5291784703-80-5
Inquiry

Comments (0)